<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Chronic hepatitis C</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Chronic hepatitis C.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/diseases/chronic-hepatitis-c.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Letter to the Editor: Efficacy and safety of the generic forms of sofosbuvir/ledipasvir in chronic hepatitis C virus adolescents in Upper Egypt</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-4254-wjh-118661-ff82a1d3/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-4254-wjh-118661-ff82a1d3/</guid>
    <pubDate>Thu, 27 Aug 2026 00:00:00 GMT</pubDate>
    <description>The authors support use of generic sofosbuvir/ledipasvir in children and adolescents in Egypt and other resource-limited countries. This relevance reflects the authors&apos; stated position and the reported study findings.</description>
    <category>Hepatitis E</category>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Gut Microbiota Recovery After Direct-Acting Antiviral Therapy for Chronic Hepatitis C: A Systematic Review and Meta-Analysis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-microorganisms14081843-c4d61cac/</guid>
    <pubDate>Wed, 19 Aug 2026 00:00:00 GMT</pubDate>
    <description>The synthesis highlights unresolved questions regarding how antiviral success translates to intestinal ecosystem restoration, indicating a documented gap in characterizing associated functional and clinical outcomes.</description>
    <category>Hepatitis C</category>
    <category>Chronic hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Treatment</category>
    <category>Systematic review</category>
  </item>
  <item>
    <title>Time to viral load suppression with 8-week versus 12-week ravidasvir/sofosbuvir regimens among chronic hepatitis C patients in Malaysia: a non-inferiority, randomized clinical trial</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13741-5-f049bb89/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-026-13741-5-f049bb89/</guid>
    <pubDate>Thu, 11 Jun 2026 00:00:00 GMT</pubDate>
    <description>The findings provide treatment-duration evidence from Malaysian adults with chronic hepatitis C and may inform further evaluation of shorter ravidasvir/sofosbuvir regimens. The abstract does not establish programmatic recommendations, population-level effectiveness, or effects on transmission or mortality.</description>
    <category>Hepatitis C</category>
    <category>Hepatitis E</category>
    <category>Chronic hepatitis C</category>
    <category>Treatment</category>
    <category>Randomised controlled trial</category>
  </item>
</channel>
</rss>
